SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-030780
Filing Date
2024-03-13
Accepted
2024-03-13 16:16:02
Documents
86
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K scph-20231231.htm   iXBRL 10-K 3250849
2 EX-10.6 scph-ex10_6.htm EX-10.6 19844
3 EX-23.1 scph-ex23_1.htm EX-23.1 5738
4 EX-31.1 scph-ex31_1.htm EX-31.1 14557
5 EX-31.2 scph-ex31_2.htm EX-31.2 14544
6 EX-32.1 scph-ex32_1.htm EX-32.1 9677
7 EX-32.2 scph-ex32_2.htm EX-32.2 8984
8 EX-97.1 scph-ex97_1.htm EX-97.1 41722
  Complete submission text file 0000950170-24-030780.txt   11370921

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT scph-20231231.xsd EX-101.SCH 1399297
88 EXTRACTED XBRL INSTANCE DOCUMENT scph-20231231_htm.xml XML 1895208
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38293 | Film No.: 24746105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)